Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-20-118585
Filing Date
2020-10-27
Accepted
2020-10-27 17:00:20
Documents
5
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2034206d1_10ka.htm 10-K/A 318097
2 EXHIBIT 31.3 tm2034206d1_ex31-3.htm EX-31.3 8495
3 EXHIBIT 31.4 tm2034206d1_ex31-4.htm EX-31.4 12143
4 EXHIBIT 32.3 tm2034206d1_ex32-3.htm EX-32.3 4488
5 EXHIBIT 32.4 tm2034206d1_ex32-4.htm EX-32.4 4852
  Complete submission text file 0001104659-20-118585.txt   349266
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-35023 | Film No.: 201264799
SIC: 2834 Pharmaceutical Preparations